Showing 1 - 6 results of 6 for search 'Jinglan Pei', query time: 0.03s Refine Results
  1. 1
    Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis

    Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) i... by Jennie H. Best, Steven C. Vlad, Jinglan Pei

    Published 2020-01-01
    Get full text
    Article
  2. 2
    Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data

    Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data by Sara Gale, Huong Trinh, Katie Tuckwell, Neil Collinson, John H. Stone, Khaled Sarsour, Jinglan Pei, Jennie Best, Christine Birchwood, Shalini V. Mohan

    Published 2019-02-01
    Get full text
    Article
  3. 3
    Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

    Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations by Sebastian Unizony, Timothy J. McCulley, Robert Spiera, Jinglan Pei, Paris N. Sidiropoulos, Jennie H. Best, Christine Birchwood, Andrey Pavlov, John H. Stone

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination

    Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination by Ilya Kister, Ryan Curtin, Amanda L. Piquet, Tyler Borko, Jinglan Pei, Barbara L Banbury, Tamar E. Bacon, Angie Kim, Michael Tuen, Yogambigai Velmurugu, Samantha Nyovanie, Sean Selva, Marie I. Samanovic, Mark J. Mulligan, Yury Patskovsky, Jessica Priest, Mark Cabatingan, Ryan C. Winger, Michelle Krogsgaard, Gregg J. Silverman

    Published 2024-07-01
    Get full text
    Article
  5. 5
    Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis

    Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis by Britney Barrera, Haley Simpson, Eric Engebretson, Stefan Sillau, Brooke Valdez, José Parra‐González, Ryan C. Winger, Lou Anne Epperson, Ashley Banks, Kathryn Pierce, Melanie Spotts, Katie O'Gean, Enrique Alvarez, Robert Gross, Amanda L. Piquet, Teri Schreiner, John R. Corboy, Jinglan Pei, Timothy L. Vollmer, Kavita V. Nair

    Published 2023-04-01
    Get full text
    Article
  6. 6
    Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies

    Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies by Ilya Kister, Ryan Curtin, Jinglan Pei, Katherine Perdomo, Tamar E. Bacon, Iryna Voloshyna, Joseph Kim, Ethan Tardio, Yogambigai Velmurugu, Samantha Nyovanie, Andrea Valeria Calderon, Fatoumatta Dibba, Igda Stanzin, Marie I. Samanovic, Pranil Raut, Catarina Raposo, Jessica Priest, Mark Cabatingan, Ryan C. Winger, Mark J. Mulligan, Yury Patskovsky, Gregg J. Silverman, Michelle Krogsgaard

    Published 2022-10-01
    Get full text
    Article

Search Tools: